ghk-cu dosage research and Protocol: The 30-Day Cycle ghk-cu peptide recommended dosage for

It suppresses pro-inflammatory cytokines (e.g., IL-1, TNF-) and NF-B signaling, reducing inflammation linked to aging and injury

they are prepared by licensed pharmacies to fill an individual prescription

A good example of this is growth hormone secretagogues peptides that facilitate growth hormone secretion whose capacity to promote physical growth can trigger the growth and spread of tumors.18 For that reason, peptides such as sermorelin, tesamorelin, and CJC-1295 are contraindicated for people with active cancer, as well as those with a personal or familial history of cancer

\n\n\n\n It is also worth noting the existence of a stabilized form known as BPC-157 arginine salt, sometimes called BPC-157 stable form or BPC-157 acetate salt

Theres a slippery slope here for sure